That was my understanding till I was shown what biotech stocks get bought out for,
the triangle report shows $5 billion of you divided that by shares on issues
(163 mill) you get just over $30 but what the triangle report does not show is that generally big pharma will add 3 to 5 times peak sale so if we go in the middle that will be 4 times 5 billion = 20 bill divided by shares on issue 163m you get
Just over $122 a share and I know that sounds insane but even Dr T said the triangle report was very very conservative.
So if we get to positive phase 3 then it's top end that's why I'll take triangles report offer for lesser trials
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-69
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.62 |
Change
0.015(0.93%) |
Mkt cap ! $276.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.55 | $456.4K | 284.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 2659 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |